Hal N Buch, MD Funding: How Much Did They Raise & Key Investors

How Much Did Hal N Buch, MD Raise?
Funding & Key Investors

Hal N Buch, MD, a prominent gastroenterology practice, has secured significant capital, with total funding reaching $129K. The practice recently announced a major strategic investment, underscoring its growth trajectory and market position in specialized digestive healthcare. This latest financing round follows previous capital infusions, indicating sustained investor confidence in the company's operational model and expansion potential.

What is Hal N Buch, MD?

Hal N Buch, MD

Hospitals & Physicians Clinics

Physicians Clinics

Medical Practice Management

Buch Gastroenterology, led by Dr. Hal N Buch, operates as a specialized medical practice focused on the diagnosis and treatment of gastrointestinal disorders. Located in Kingston, NY, the practice offers comprehensive services including colonoscopy, upper endoscopy, and IV vitamin infusion therapy. It is equipped with a state-of-the-art, AAAASF accredited facility, emphasizing advanced endoscopic techniques and patient-centric care. With over two decades of experience, Dr. Buch is dedicated to both treating existing digestive diseases and promoting preventative care, positioning the practice as a key provider in its service area.

How much funding has Hal N Buch, MD raised?

Hal N Buch, MD has raised a total of $129K across 1 funding round:

2021

Debt

$129K

Debt (2021): $129K with participation from PPP

What's next for Hal N Buch, MD?

The recent strategic investment signals a pivotal moment for Hal N Buch, MD, likely enabling the practice to expand its service offerings, enhance its technological infrastructure, or broaden its geographic reach. As a late-stage entity, this capital infusion is expected to fuel further operational scaling and solidify its competitive advantage in the gastroenterology sector. Future developments may include the adoption of new diagnostic tools, increased patient outreach programs, or strategic partnerships to enhance patient care pathways and operational efficiency.

See full Hal N Buch, MD company page

See More Financial Insights